Edoxaban

Trade Name: 
Lixiana
Manufacturer/Distributor: 
Servier Canada Inc.
Classification: 
Anticoagulant
ATC Class: 
B01AF - direct factor Xa inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2016/11/04
Date Marketed in Canada (yyyy/mm/dd): 
2017/01
Presentation: 
Tablet: 15 mg. DIN: 02458640
Tablet: 30 mg. DIN: 02458659
Tablet: 60 mg. DIN: 02458667
Comments: 
Anticoagulant for prevention of stroke and systemic embolic events in patients with atrial fibrillation. For treatment of venous thromboembolism and pulmonary embolism and prevention of deep vein thrombosis and pulmonary embolism.